on The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Group Discloses Stake in Mural Oncology
The Vanguard Group, Inc. recently filed an opening position disclosure under Rule 8.3 with the Irish Takeover Panel regarding its interests in Mural Oncology plc. The disclosure is part of compliance with takeover rules established in 2022.
As of May 21, 2025, Vanguard controls 772,921 ordinary shares, representing a 4.48% stake in Mural Oncology. This position involves no cash-settled or stock-settled derivatives.
On the dealings front, the group recorded a sale of 36 shares at a price of 2.76 USD per unit. No additional derivative transactions or new securities dealings were noted.
The disclosure mentions no indemnity, options, or agreements to influence dealings, nor were any supplemental forms attached. Details were confirmed by contact Shawn Acker on May 22, 2025.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news